ACTRN12618001269224招募中未知
An international, multicentre RCT to evaluate the use of adapted classical literature in book groups for people living with dementia at aged care facilities: can quality of life be improved?
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 260
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Medical diagnosis of dementia
- •living in a rest home or hospital level care
- •adequate communication skills as measured on the InterRAI
- •No problems with verbal or physical abuse, No socially disruptive behaviour
- •provide consent
- •score between 36 and 82 on the Addenbrooks at baseline
排除标准
- •co-morbidity which would preclude them from participating for 7 weeks
研究者
相似试验
进行中（未招募）
1 期
A clinical study with many of countries and sites participating. This study wants to look into the relationship of the genotype IL28B in patients from all over the world which are suffering from an inflammation of the liver with hepatitis C virusEUCTR2011-001096-39-SKF.Hoffmann-La Roche Ltd.4,200
进行中（未招募）
1 期
A MULTINATIONAL, MULTICENTER STUDY TO ASSESS THE EFFECTS OF ORAL SILDENAFIL ON MORTALITY IN ADULTS WITH PULMONARY ARTERIAL HYPERTENSIOMedDRA version: 17.1Level: PTClassification code 10064911Term: Pulmonary arterial hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersPulmonary Arterial HypertensionEUCTR2013-004362-34-GRPfizer Inc., 235 East 42nd Street, New York, NY 10017429
进行中（未招募）
1 期
A MULTINATIONAL, MULTICENTER STUDY TO ASSESS THE EFFECTS OF ORAL SILDENAFIL ON MORTALITY IN ADULTS WITH PULMONARY ARTERIAL HYPERTENSIOPulmonary Arterial HypertensionEUCTR2013-004362-34-CZPfizer Inc., 235 East 42nd Street, New York, NY 10017429
进行中（未招募）
1 期
A MULTINATIONAL, MULTICENTER STUDY TO ASSESS THE EFFECTS OF ORAL SILDENAFIL ON MORTALITY IN ADULTS WITH PULMONARY ARTERIAL HYPERTENSIOPulmonary Arterial HypertensionMedDRA version: 20.0Level: PTClassification code 10064911Term: Pulmonary arterial hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2013-004362-34-BEPfizer Inc., 235 East 42nd Street, New York, NY 10017429
进行中（未招募）
1 期
A MULTINATIONAL, MULTICENTER STUDY TO ASSESS THE EFFECTS OF ORAL SILDENAFIL ON MORTALITY IN ADULTS WITH PULMONARY ARTERIAL HYPERTENSIOPulmonary Arterial HypertensionEUCTR2013-004362-34-PTPfizer Inc., 235 East 42nd Street, New York, NY 10017429